Delivery Order SPE2DR25D1017-SPE2DR26F9AJS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,447.89 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on October 28, 2025, with an ultimate completion date of October 29, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania headquarters. The award represents a competitive procurement under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $47,292.82 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded delivery order was executed on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used for cholesterol...
- The Defense Logistics Agency awarded a delivery order valued at $8,232.28 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- The Defense Logistics Agency awarded a $2,455.27 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors. This firm fixed price, non-set-aside contract was awarded on October 23, 2025, with an ultimate completion date of October 24, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...
- The Defense Logistics Agency awarded a delivery order valued at $5,310.61 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector units under a firm fixed price contract. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor medication used for...
- The Defense Logistics Agency awarded a delivery order valued at $2,157.40 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 23, 2025. This non-competitive delivery order represents a firm fixed-price transaction executed on October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor prescribed for patients with high cholesterol and...
- The Defense Logistics Agency awarded a delivery order valued at $55,027.37 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on August 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AJSDelivery Order
The Defense Logistics Agency awarded a $2,280.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors, with an ultimate completion date of November 28, 2025. This non-set-aside contract was awarded competitively on November 26, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for military healthcare programs worldwide. REPATHA is a prescription medication used to reduce cholesterol levels and cardiovascular risk, and the auto-injector formulation enables patient self-administration. As a child contract under the DLA's comprehensive pharmaceutical prime vendor program, this delivery order reflects AmerisourceBergen's critical role in supplying brand-name medications and specialty pharmaceuticals to support Defense Health Agency operations and other federal healthcare systems globally. The award demonstrates the contractor's continued capability to fulfill federal medical procurement requirements through competitive processes and supports the broader military healthcare supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/25/25 |